By licensing our intellectual property, we make sure that knowledge developed at the Crick can benefit people’s health through commercial products or services.
We want to recognise a company’s success with late-stage clinical milestones and royalties, rather than a requirement for short-term profitability. We believe that license fees and premature development requirements can stifle innovation and slow down progress on a project
Mapping the brain
A patent has been filed on electrode technology arising from neuroscience research carried out in Andreas Schaefer’s lab, a technology which could have a wide range of applications. Researcher Romeo Racz developed very fine electrodes to record electric signals from nerve cells for neurophysiology studies.
The ability to map neural circuits in the brain with such precision is of great interest, and the Crick is working with a UK company to make the electrodes available for research laboratories.
There are also potential applications in medicine. Having consulted clinicians, the group has identified unmet medical needs for fine-scale bioelectronic needles and devices. Several projects are underway to develop and test such products with the possibility of working with others to take them further.